Result of AGM

THE BIOTECH GROWTH TRUST PLC

Results of the Annual General Meeting

The following resolutions were passed at the Annual General Meeting of the Company held on Wednesday, 15 July 2020 and the level of proxy votes received is shown below.

Resolutions Votes For % Votes Against % Total Votes Cast Votes
Withheld*
Ordinary Business
1.To accept the audited accounts and the Report of the Directors for the year ended 31 March 2020. 15,692,683 100.00%
154
0.00% 15,692,837 1,116
2.To approve the Directors’ Remuneration Report. 15,681,025 99.94% 9,370 0.06% 15,690,395 3,558
3.To approve the Directors’ Remuneration Policy. 15,682,095 99.95% 8,300 0.05% 15,690,395 3,558
4.To re-elect Mr Andrew Joy as a Director of the Company.
15,689,111
100.00% 296 0.00% 15,689,407 4,546
5.To re-elect Professor Dame Kay Davies CBE as a Director of the Company.
15,689,688
99.99% 1,402 0.01% 15,691,090 2,863
6.To re-elect Mr Steve Bates as a Director of the Company.
15,689,253
100.00% 154 0.00% 15,689,407 4,546
7.To re-elect The Rt Hon Lord Willetts as a Director of the Company.
14,607,129
93.09% 1,084,543 6.91% 15,691,672 2,280
8.To re-elect Mrs Julia Le Blan as a Director of the Company.
15,688,452
100.00% 296 0.00% 15,688,748 5,205
9.To re-elect Mr Geoff Hsu as a Director of the Company.
14,614,147
93.15% 1,075,417 6.85% 15,689,564 4,388
10.To appoint BDO LLP as auditor and to authorise the Audit Committee to determine their remuneration.

15,682,455
99.93% 10,385 0.07% 15,692,840 1,113
Special Business
11.To authorise the Directors to allot securities in the Company. (Ordinary Resolution)
15,678,178
99.91% 14,222 0.09% 15,692,400 1,553
12. To disapply the rights of pre-emption in relation to the allotment of securities. (Special Resolution)
15,659,934
99.81% 29,993 0.19% 15,689,927 4,026
13. To authorise the Company to make market purchases of Ordinary shares in the Company. (Special Resolution)
15,682,532
99.93% 10,365 0.07% 15,692,897 1,055
14. That the Directors be permitted to hold General Meetings (excluding the AGM) on not less than 14 clear days’ notice. (Special Resolution)
15,626,052
99.57% 67,232 0.43% 15,693,284 669
15. To approve the continuance of the Company as an investment trust for a further period of five years. 14,621,155 99.99% 1,587 0.01% 14,622,742 1,071,211

* Please note that ‘Vote withheld’ is not a vote in law and is not counted in the calculation of the proportion of votes ‘For’ and ‘Against ‘a resolution.

Any proxy votes which are at the discretion of the Chair of the Meeting have been included in the "for" total. A vote withheld is not a vote in law and is not counted in the calculations of votes cast by proxy.

At the date of the AGM the total number of Ordinary shares of 25p each in issue and the total number of voting rights was 39,332,269.

The proxy voting figures will shortly also be available on the Company’s website at http://www.biotechgt.com/

In accordance with Listing Rule 9.6.2, the full text of the special business resolution passed has been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism. The special business resolutions will additionally be filed at Companies House.

15 July 2020

For further information please contact:

Mark Pope  Frostrow Capital LLP – Company Secretary  020 3 008 4913

Investor Meets Company
UK 100